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CMV and HSVAbstract Background: High Risk Pregnancy (HRP) is a condition where mother or developing
fetus or both are at increased risk of complications during or after pregnancy and birth. There
are no studies so far which have characterized congenital anomalies (CAs) in HRP women with dif-
ferent previous obstetric histories.
Aim: The present study was aimed to determine the prevalence, types and distribution of various
CAs and also to find out the exact risk factors for different obstetric histories.
Subjects and methods: A total of 3301 HRP women (2011–2014) were enrolled. Diagnosis was
made using 3D/4D ultrasound. Serum was analyzed for IgG & IgM against TORCH (Toxoplasma,
Rubella, CMV and HSV) agents by ELISA. Eleven percent were pregnant women carrying fetuses
with CAs in the present pregnancy, while remaining 89% were with bad obstetric history (BOH)
and other medical and obstetric complications.
Results: Eleven percent pregnant women were carrying fetuses with CAs in the present preg-
nancy. The major CAs observed were Central Nervous System (CNS) followed by renal anomalies.
Maternal age (625 years, OR = 1.42, p= 0.002), paternal age (<30 years, OR = 1.51,
p< 0.001), consanguinity (OR = 1.39, p= 0.012) and primi gravida (OR= 3.40, p< 0.001) were
identified as risk factors for HRP women with fetal CAs in present pregnancy. Maternal age
625 years and paternal age <30 years conferred around 2-fold risk toward CAs in primi gravida
women (p< 0.001) whereas consanguinity was associated with CAs in HRP women with BOH
(OR= 1.95, p< 0.018). Toxoplasmosis played a significant role in pregnant women with CAs
in present pregnancy with previous normal pregnancies (OR = 4.45, p= 0.009).
Conclusion: High prevalence of CAs was found in HRP women compared to general population.
Low parental age contributed toward CAs in primi gravida women while consanguinity was found
to be a predisposing factor for CAs in HRP with previous BOH. Toxoplasmosis conferred risk for
CAs in HRP women with previous normal pregnancies.
 2016 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).500016,
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2 T. Sunitha et al.1. Introduction
High Risk Pregnancy (HRP) is a condition where the mother
or the developing fetus or both are at an increased risk for
complications during or after pregnancy and birth [1]. Congen-
ital anomalies are the leading causes of mortality in developed
and developing countries [2]. Approximately 50% of all con-
genital malformations cannot be linked to a specific cause.
BOH implies previous unfavorable fetal outcome in terms of
two or more consecutive spontaneous abortions, history of
intrauterine fetal death, intrauterine growth retardation, still-
birth, early neonatal death and congenital anomalies.
Till date several studies in developed countries have been
performed to assess the determinants for HRP but the risk fac-
tors varied with respect to different ethnic groups [3–4]. In
addition, there are no studies so far which have characterized
congenital anomalies in HRP women with different previous
obstetric histories. Thus, the present study was aimed to deter-
mine the prevalence, types and distribution of various CAs and
also to find out the exact risk factors for different obstetric
histories.
2. Subjects and methods
A total of 3301 HRP women attending antenatal clinic of
Modern Government Maternity Hospital, Hyderabad during
3 years (2011–2014) were enrolled. Diagnosis was made using
3D/4D ultrasound by fetal medicine specialists at Institute of
Genetics and Hospital for Genetic Diseases, Osmania Univer-
sity, Hyderabad. The anomalies identified were classified
according to the International Classification of Disease, Tenth
Revision codes (http://apps.who.int/classifications/). The HRP
women were personally interviewed, counseled and the
detailed history has been recorded in a special proforma with
regard to demographic characteristics such as parental age,
consanguinity, BOH, gravida, religion, parental education,
occupation, socioeconomic status, and maternal infections like
TORCH (Toxoplasma, Rubella, Cyto MegaloVirus and Her-
pes Simplex Virus) etc. Pregnant women with congenital
anomalies in present pregnancy, BOH, maternal diabetes,
hypertension, epilepsy etc., were included in the study. The
work has been carried out in accordance with the code of
Ethics of The World Medical Association for experiments in
humans. Study was approved by the Institutional Ethics Com-
mittee and informed consent was obtained from all pregnant
women prior enrollment.
Two milliliter of blood was aseptically drawn by venipunc-
ture into a tube containing clot activator from a total of 291
HRP women with fetal CAs in the present pregnancy. They
were then centrifuged and serum was separated. The levels of
IgG and IgM were measured using commercially available
ELISA kits (Euroimmun, Germany), and Optical Density
(OD) was measured at 450 nm in a microplate ELISA reader
(Bio-Rad, USA) according to manufacturer instructions. The
results were interpreted on the basis of Immune Status Ratio
(ISR) index calculated by dividing the specimen OD value by
the cut-off calibrator ratio. The tests were considered seropos-
itive if ISR value is P1.11 and considered seronegative if ISR
60.9. Samples with an ISR value in between 0.9 and 1.10 were
considered equivocal.Please cite this article in press as: Sunitha T et al., Risk factors for congenital anoma
Hum Genet (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.04.001Statistical analysis was performed using test of proportion
online calculator (http://in silico.net/tools/statistics/ztest/)
and openepi software (http://www.openepi.com). Differences
between groups were determined by v2 test and risk analysis
was performed by calculating Odds ratio (OR) at 95% CI. A
two tailed p-value of <0.05 was considered to be significant.3. Results
Out of 3301 HRP women, 11% (360/3301) were pregnant
women carrying fetuses with CAs in the present pregnancy
(Group 1), while remaining 89% (2941/3301) were with BOH
and other medical and obstetric complications (Group 2).
Out of 360 pregnant women, 130 (36%) were primi gravida
pregnant women with fetal CAs in the present pregnancy,
145 (40%) were pregnant women with fetal CAs in present
pregnancy with previous normal pregnancies while remaining
85(24%) were pregnant women with fetal CAs in present preg-
nancy with previous BOH. Among 89% of HRP women with
BOH and other medical and obstetric complications, 72%
(2379) were with BOH, 12% (401) of women presented with
hypertension, heart disease, diabetes, epilepsy etc., while 161
(5%) HRP women were carrying twins or triplets (Fig. 1).
When the identified congenital anomalies were classified
according to the International Classification of Disease, the
most common system affected was central nervous system
(CNS) (37%) [isolated hydrocephalous, hydrocephalous with
neural tube defect, microcephaly, choroid plexus cyst, intra
cardiac focus, dilatation of occipital horn of right lateral ven-
tricle, holoprosencephaly, cystic hygroma with gross hydro-
cephalous, bilateral ventriculomegaly, dandy walker
malformations, Arnold Chiari malformation, giant cisterna
magna, anencephaly, meningomyelocele, encephalocele, spina
bifida etc.], followed by renal anomalies (20%) [dysplastic kid-
neys, poly cystic kidneys, multi cystic kidneys, hydronephrosis,
echogenic kidneys, bilateral pyelectiasis, bilateral renal pelvis
prominent, horse shoe kidney, membrano proliferative
glomerular nephritis, asymmetric dilatation etc.], multiple
anomalies (11%) [congenital heart disease with omphalocele
and cleft lip, bilateral club foot with hydrocephalous,
hydronephrosis with hydrocephaly, gross hydrocephalus with
cleft lip and cleft palate, IUGR with fetal left hydronephrosis,
hydrocephalus with dysplastic kidneys, kyphoscoliosis with
omphalocele, club foot and club hands with hydrocephalus,
dandy walker with congenital left diaphramatic hernia, hydro-
cephalus with renal dysplasia, anencephaly with omphalocele,
hydrocephalus with dysplastic kidneys, dilated ventricles with
multiple anomalies of the abdomen-ascites, pleural effusion,
hydrops fetalis, cystic hygroma with skeletal deformity, single
umbilical artery with hyper echogenic bowels and lungs, echo-
genic bowels with left kidney pyelectasis, asymmetry of fetal
heart chambers with bilateral hydronephrosis, fetal congenital
diaphramatic hernia with occipital encephalocele, kyphoscol-
iosis with spina bifida, sacral meningocele and omphalocele,
fetal spina bifida with club foot, kyphoscoliosis with lateral
ventricle prominent, anencephaly with diaphramatic hernia
and left hydro utero nephrosis, club foot with omphalocele
and spinal deformity etc.], musculoskeletal system [kyphosco-
liosis, achondroplasia, recurrent osteogenesis imperfecta,
dwarfism, brachycephaly, hemi vertebrae, dolicocephalus,lies in high risk pregnant women: A large study from South India, Egypt J Med
Figure 1 Characteristics of High Risk Pregnancy (HRP) Group.
High risk pregnancies 3bilateral talipes equinogenesis, short limbs, club foot, fetal
lower limb deformity] were seen in 8% cases, Gastrointestinal
tract abnormalities [omphalocele, gastroschisis, duodenal atre-
sia, absent stomach bubble, esophageal atresia, echogenic
bowel, anterior abdominal wall defect, absent fetal gastric bub-
ble, exomphalocele etc.] were found in 6% cases. Cardiovascu-
lar System disorders [atrial and ventricular septal defects,
pericardial effusion, small sized pulmonary artery, over riding
of aorta, cardiomegaly, single atrium, small foci in left ventri-
cle, left heart hypoplasia etc.] were detected in 5% cases. Lym-
phatic defects [cystic hygroma, hydrops fetalis, ascites, absent
nasal bone] were found in 4% cases. Respiratory system disor-
ders [bilateral pleural effusion, diffusely hyperechoic, narrow-
ing of chest wall] were seen in 1% of the cases. Urinary
system defects [hydroureters, pelvi ureteric junction (PUJ)
obstruction, megacystis] were observed in 1% of the cases.
Syndromes [Meckel-Gruber syndrome, Holt Oram syndrome,
Turners syndrome - fetal hydrops and cystic hygroma] were
observed in 1% of the cases. Facial anomalies [cleft lip, cleft
palate, cleft lip of fortus, cleft lip and palate] were detected
in 1% of the cases (Fig. 2).
Demographic characteristics among these groups revealed
maternal age 625 years [OR = 1.42(1.31–1.78), p= 0.002],
paternal age <30 years [OR = 1.51(1.20–1.90), p< 0.001]Figure 2 Distribution of cong
Please cite this article in press as: Sunitha T et al., Risk factors for congenital anoma
Hum Genet (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.04.001and consanguinity [OR = 1.39(1.08–1.80), p= 0.012] as the
predisposing factors toward CAs for Group 1. Additionally,
primi gravida women of Group 1 were also more likely (3-
fold) to have fetal anomalies [OR = 3.40(2.68–4.31),
p< 0.001] (Table 1).
Group 1 women were carrying fetuses with CAs in the pre-
sent pregnancy irrespective of their previous history of BOH or
normal pregnancy or primi gravida. Thus, they were further
classified into three sub-groups viz. Group A – Primi gravida
pregnant women with fetal CAs in present pregnancy, Group
B – Pregnant women with fetal CAs in present pregnancy with
previous normal pregnancies and Group C – Pregnant women
with fetal CAs in present pregnancy with previous BOH.
Detailed evaluation of the groups with respect to epidemiolog-
ical factors and TORCH infections, demonstrated a significant
contribution of 625 years maternal age [OR = 2.35(1.46–3.79,
p< 0.001], and <30 years paternal age [OR = 2.30(1.41–
3.74), p< 0.001], toward group A whereas consanguinity
[OR = 1.95(1.15–3.31), p= 0.018] was associated with group
C (Table 2). Evaluation of seropositivity for TORCH agents
within the sub-groups (A, B and C), did not show its influence
toward CAs in groups A and C. However, HRP women in
group C showed 4.45 fold risk for having fetal CAs in present
pregnancy [OR = 4.45(1.44–12.5), p= 0.009] (Table 3).enital anomalies in group 1.
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Table 1 Distribution of demographic characteristics in Group 1 and Group 2.
Variable Group 1 N(%) 360 Group 2 N(%) 2941 OR(95%CI) p-value
Maternal age
625 yrs 228(63) 1613(55) 1.42(1.13–1.78) S
>25 yrs 132(37) 1328(45)
Paternal age
<30 yrs 236(65) 1638(56) 1.51(1.20–1.90) S
P30 yrs 124(35) 1303(44)
Consanguinity
Yes 90(25) 567(19) 1.39(1.08–1.80) S
No 270(75) 2374(81)
Gravida
Primi gravida 130(38) 419(14) 3.40(2.68–4.31) S
Multi gravida 230(62) 2522(86)
Religion
Hindu 248(69) 1925(66) 1.16(0.92–1.47) NS
Muslim 112(31) 1016(34)
Maternal Education
Primary and less 126(35) 1059(36) 0.95(0.76–1.2) NS
Secondary and above 234(65) 1882(64)
Paternal education
Primary and less 187(52) 1529(52) 0.99(0.80–1.24) NS
Secondary and above 173(48) 1412(48)
Maternal occupation
House wives 314(88) 2649(90) 0.75(0.53–1.04) NS
Laborers 19(5) 141(5) 1.10(0.67–1.81) NS
Agricultural workers 15(4) 71(2) 1.75(0.99–3.10) NS
Professionals 12(3) 80(3) 1.23(0.66- 2.28) NS
Paternal occupation
Drivers 77(21) 588(20) 1.08(0.83–1.42) NS
Agricultural workers 67(19) 537(18) 1.02(0.77–1.35) NS
Professionals 67(19) 531(18) 1.03(0.78–1.37) NS
Laborers 51(14) 542(18) 0.73(0.53–0.99) NS
Traders 48(13) 371(13) 1.06(0.77–1.47) NS
Technical workers 29(8) 239(8) 0.99(0.66–1.48) NS
Industrial 16(5) 107(4) 1.23(0.72–2.10) NS
Hospital workers 5(1) 26(1) 1.57(0.47–4.21) NS
Family Income
<10,000 336(93) 2775(94) 0.83(0.53–1.30) NS
>10,000 24(7) 166(6)
Maternal diabetes/hypertension/ /epilepsy/heart disease etc.
Yes 40(11) 401(12) NS
No 320(89) 2540(88) 0.79(0.56–1.11)
Family H/o congenital anomalies/mental retardation/genetic diseases
Yes 36(10) 353(12)
No 324(90) 2588(86) 0.81(0.56–1.17) NS
Group 1 – High risk pregnant women carrying fetuses with CAs in the present pregnancy.
Group 2 – High risk pregnant women with History of repeated abortions, previous CAs, previous intra uterine deaths, previous neonatal deaths,
previous preterm births and other medical & obstetric complications.
OR: Odds ratio, CI: Confidence Interval.
p< 0.05 is considered to be statistically significant, S – Significant, NS – Non-significant.
4 T. Sunitha et al.4. Discussion
High Risk Pregnancy is a major worldwide health problem
demonstrating an increased risk of perinatal and maternal
mortality. The present study was attempted to evaluate the
burden of CAs in HRP women and also to assess the risk fac-
tors contributing to HRP as CAs are among the major causesPlease cite this article in press as: Sunitha T et al., Risk factors for congenital anoma
Hum Genet (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.04.001of morbidity and mortality in many countries around the
world. To the best of our knowledge the present study is the
first of this kind in India.
In our study, 11% of CAs observed was almost double than
reported among the general population in India (6%) [5]. The
joint World Health Organization (WHO) and March of Dimes
(MOD) meeting reported that 7% of all neonatal mortalitylies in high risk pregnant women: A large study from South India, Egypt J Med
Table 2 Distribution of demographic characteristics in groups A, B and C of Group 1.
Variable Group A (n= 130) Group B (n= 145) Group C (n= 85) A vs. Others B vs. Others C vs. Others
n (%) n (%) n (%) OR p-value OR p-value OR p-value
Maternal age
625 yrs 98 (75) 84 (58) 46 (54)
>25 yrs 32 (25) 61 (42) 39 (46) 2.35(1.46–3.79) S 0.67(0.43–1.04) NS 0.60(0.36–0.98) NS
Paternal age
<30 yrs 100 (77) 86 (59) 50 (59)
P30 yrs 30 (23) 59 (41) 35 (41) 2.30(.1.41–3.74) S 0.63(0.40–0.98) NS 0.68(0.41–1.12) NS
Consanguinity
Yes 25 (19) 35 (24) 30 (35)
No 105 (81) 110 (76) 55 (65) 0.60(0.35–1.01) NS 0.92(0.56–1.50) NS 1.95(1.15–3.31) S
Gravida
Primi gravida 130 (100) 0 (0) 0(0) – – – – – –
Multi gravida 0 (0) 145 (100) 85 (100)
Religion
Hindu 93 (72) 95 (66) 60 (71)
Muslim 37 (28) 50 (34) 25 (29) 1.21(0.76–1.94) NS 0.76(0.48–1.21) NS 1.11(0.65–1.88) NS
Maternal education
Primary and less 43 (33) 46 (32) 37 (44)
Secondary and above 87 (67) 99 (68) 48 (56) 0.87(0.55–1.37) NS 0.78(0.50–1.22) NS 1.61(0.97–2.65) NS
Paternal education
Primary and less 59 (45) 84 (58) 44 (52)
Secondary and above 71 (55) 61 (42) 41 (48) 0.66(0.42–1.02) NS 1.49(0.97–2.28) NS 0.99(0.60–1.61) NS
Maternal occupation
House wives 112 (86) 128 (88) 74 (87) 0.86(0.45–1.62) NS 1.17(0.61–2.22) NS 0.98(0.47–2.02) NS
Laborers 9 (7) 5 (4) 5 (6) 1.63(0.64–4.13) NS 0.51(0.18–1.45) NS 1.16(0.40–3.33) NS
Agricultural 5 (4) 6 (4) 4 (5) 0.88(0.29–2.63) NS 0.98(0.34–2.83) NS 1.18(0.26–4.13) NS
Professionals 4 (3) 6 (4) 2 (2) 0.88(0.19–3.36) NS 1.50 (0.39–5.74) NS 0.63(0.06–3.08) NS
Paternal occupation
Drivers 21 (16) 35 (24) 21 (25) 0.59(0.34–1.04) NS 1.31(0.78–2.17) NS 1.28(0.72–2.27) NS
Agricultural 25 (19) 28 (19) 14 (16) 1.06(0.61–1.84) NS 1.08(0.63–1.85) NS 0.82(0.43–1.57) NS
Professionals 28 (22) 23 (16) 16 (19) 1.34(0.78–2.31) NS 0.73(0.42- 1.27) NS 1.01(0.54–1.89) NS
Laborers 16 (12) 17 (12) 18 (21) 0.78(0.41–1.47) NS 0.70(0.37–1.32) NS 1.97(1.04–3.71) NS
Traders 21 (16) 21 (15) 6 (7) 1.44(0.78–2.68) NS 1.17(0.63–2.17) NS 0.42 (0.17–1.02) NS
Technical workers 10 (8) 15 (10) 4 (5) 0.92(0.41–2.05) NS 1.65(0.77–3.54) NS 0.49(0.16–1.46) NS
Industrial 7 (5) 4 (3) 5 (6) 1.39(0.50–3.84) NS 0.47(0.15–1.51) NS 1.49(0.39–4.84) NS
Hospital workers 2 (2) 2 (1) 1 (1) 1.18(0.09–10.4) NS 0.98(0.08–8.74) NS 0.80(0.01–8.30) NS
Family income
<10,000 118 (91) 139 (96) 79 (93)
>10,000 12 (9) 6 (4) 6 (7) 0.54(0.23–1.24) NS 2.11(0.81–5.46) NS 0.92(0.35–2.40) NS
Group A – Primi gravida pregnant women with CAs in present pregnancy.
Group B – Pregnant women with CAs in present pregnancy with previous normal pregnancies.
Group C – Pregnant women with CAs in present pregnancy with previous BOH.
OR: Odds ratio, CI: Confidence Interval.
p< 0.05 is considered to be statistically significant, S – Significant, NS – Non-significant.
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Table 3 TORCH infections in groups A, B and C of Group 1.
Type of
pathogen
Group A (n= 81) Group B (n= 145) Group C (n= 65)
IgG + IgM
N(%)
IgG
N(%)
OR (95% CI) p-value IgG + IgM
N(%)
IgGN(%) OR (95% CI) p-value IgG + IgM
N(%)
IgG
N(%)
OR
(95% CI)
p-value
T. gondii 3(4) 16(20) 2.86(0.47–12.0) NS 7(5) 37(26) 4.45(1.44–12.5) S 7(11) 13(20) – –
Rubella 6(7) 72(89) 1.68(0.48–5.34) NS 5(3) 139(96) 0.53(0.19–1.48) NS 0(0) 59(91) – –
CMV 3(4) 77(95) 0.60(0.10–2.26) NS 9(6) 136(94) 1.30(0.54–3.12) NS 0(0) 59(91) – –
HSV 4(5) 48(60) 1.39(0.31–4.86) NS 1(1) 80(55) 0.18(0.00–1.19) NS 0(0) 48(74) – –
Group A – Primi gravida pregnant women with CAs in present pregnancy.
Group B – Pregnant women with CAs in present pregnancy with previous normal pregnancies.
Group C – Pregnant women with CAs in present pregnancy with previous BOH.
OR: Odds ratio, CI: Confidence Interval, p< 0.05 is considered to be statistically significant, S – significant, NS – non-significant.
CMV-Cyto Megalo Virus; HSV-Herpes Simplex Virus.
6 T. Sunitha et al.and 3.3 million under five deaths were due to CAs [6]. The inci-
dence of BOH among HRP women in the present study was
72%, which is significantly higher than a prospective study car-
ried out in North Central India (5.27%) [7]. This wide dispar-
ity in the higher incidences of CAs and BOH in our study may
be attributed to sample size variation and rapid improvements
in prenatal diagnosis, inclusion of minor anomalies and geo-
graphical factors.
Surveillance of CAs in the present study demonstrated the
highest frequency of CNS anomalies and is consistent with
previous reports in various ethnic groups [8–10]. Studies by
Sheeba et al. [11] and Akruti et al. [12] from India also
reported CNS anomalies to be the most frequent anomalies
in still borns and new borns [11–12]. However, there were no
reports pertaining to CAs in HRP women. The second com-
monest anomaly observed was renal accounting for 20% of
CAs and is almost ten times (0.2%) higher than that reported
in a prospective study by Sanghvi et al. in Mumbai [13]. The
variations in the frequencies could be due to genetic back-
ground, geographical area, socioeconomic and nutritional sta-
tus. The 3D/4D ultrasound scanning performed prenatally for
all HRP women has led to the improved detection of CAs in
our study.
The fetuses with lethal CNS anomalies often die in-utero or
in the immediate perinatal period. The other non-lethal CNS
anomalies may present with functional abnormalities like
neuro developmental failure ranging from mild mental retar-
dation, seizures to severe neurological disability i.e., deafness,
speech abnormalities and congenital ophthalmic abnormali-
ties. Structural abnormalities associated with CNS anomalies
include microcephaly, hydrocephalous etc. Renal abnormali-
ties in fetus may frequently present with mild to severe pyelec-
tasis and bladder dysjunction like in posterior urethral valves
and other anatomical abnormalities like polycystic kidneys
may be present as large hyper echogenic kidneys and multiple
cystic lesions in multi cystic kidneys. Fetuses with the polycys-
tic kidney are lethal. Multi cystic kidney and polycystic kidney
may present with enlarged kidneys in postnatal life. Pyelectasis
may present with the features ranging from recurrent urinary
tract infections to renal failure. Cardiovascular abnormalities
may present with simple anatomical abnormalities like defect
in the septum to complete developmental failure of one of
the ventricle and functional abnormalities and may present
with abnormal rhythms. Postnatally, these cases may present
with features ranging from cyanosis to failure to thrive. Often,
the complete failure of development of ventricle and severePlease cite this article in press as: Sunitha T et al., Risk factors for congenital anoma
Hum Genet (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.04.001rhythm abnormalities are fatal. Gastrointestinal abnormalities
vary from gastroschisis, omphalocele, imperforated anus, and
intestinal obstruction at various levels. The frequently seen
anatomical abnormality in respiratory system is congenital
cystic adenomatoid malformation (CCAM). These are the
common characteristics of the major systems.
Group 1 subjects with lower maternal age of 625 years and
paternal age <30 years were at an increased risk of CAs dur-
ing pregnancy and this was in accordance with previous
reports [14–16]. The mechanism responsible for such associa-
tion is not known [17]. However, this increased risk among
younger parents could be due to interaction of unknown
genetic factors or environmental factors. The identification
of novel risk factors for CAs by thorough investigation of
age-specific parental behaviors may provide insights into
etio-pathophysiology and preventive strategies of CAs. Other
factor that has been repeatedly found to be associated with
CAs in South India is consanguineous marriage, where it is
practiced as an important social culture. Nearly 20% of
HRP women of our study were married either to first or sec-
ond cousins. Among the subgroups, group 1 women revealed
around 1.4 fold risk for CAs which corresponds to earlier stud-
ies [18–20]. The incidence of CAs is higher in offsprings born
to consanguineous couples since they express the homozygous
genes inherited from their common ancestors [21]. In addition,
primi gravida was observed to be associated with increased
prevalence of CAs which could be due to unknown causes
and is consistent with the findings of Truong et al. [22].
HRP women of group 1 had fetal CAs in present pregnancy
and presented with different obstetric histories. Hence to know
the exact causative factors in each group, group 1 was divided
into three groups (A, B and C). Distribution of demographic
characteristics demonstrated that the factors like parental
age conferred around 2 fold risk for CAs in primi gravida
HRP women with CAs in the present pregnancy of group A,
the mechanism for which is unknown. Consanguinity con-
tributed toward HRP women with fetal CAs in the present
pregnancy with BOH of group C.
Asymptomatic and chronic infections play a crucial role in
pregnancy loss associated with CAs, BOH and HRP. Our pre-
vious report on TORCH infections in HRP women demon-
strated that IgG rubella and IgG CMV have a predisposing
role for HRP while IgG toxoplasmosis confers protection. In
addition, toxoplasma and rubella were showing a predisposing
role toward BOH and congenital malformations respectively
[23]. Analysis of TORCH infections in the three subgroups,lies in high risk pregnant women: A large study from South India, Egypt J Med
High risk pregnancies 7demonstrated IgG and IgM seropositivity for toxoplasmosis in
group B and revealed an OR of 4.45 indicating that these HRP
women with present CAs and with previous normal pregnan-
cies were having around 4 fold risk of having CA. These results
indicate a recent infection of toxoplasma where the transmis-
sion rate is as high as 90% for third trimester [24].
Though the preconception folic acid administration is a
routine practise in this country almost all the high risk preg-
nant women included in the study are illiterates and belong
to rural areas. Such advice for preconception folic acid was
not followed by these patients. We reiterated the fact that pre-
conceptional folic acid supplementation plays a pivotal role in
prevention of congenital anomalies and counseled them to seek
medical advice well in advance before planning for next preg-
nancy and also advised them to consume foods which are rich
in folic acid.
5. Conclusion
Our study is the first to determine the burden of CAs in HRP
women. A high prevalence (11%) of CAs was found in these
women compared to general population (6%). The major
CAs observed were CNS followed by renal anomalies. Mater-
nal age (625 yrs), Paternal age (<30 yrs), primi gravida and
consanguinity contributed to the burden of CAs in HRP.
Additionally, 625 yrs maternal age and <30 yrs paternal age
contributed toward CAs in primi gravida women. Consanguin-
ity was found to be a predisposing factor for CAs in HRP with
previous BOH while toxoplasma seropositivity conferred risk
for pregnant women with CAs in present pregnancy with pre-
vious normal pregnancies. As CAs continue to be an impor-
tant cause of morbidity and mortality especially in
developing countries, advanced screening methods for early
diagnosis of HRP may help in appropriate intervention and
proper management of congenital anomalies.
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